The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men
Open Access
- 14 March 2009
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 52 (7) , 1298-1307
Abstract
We studied the physiological, metabolic and hormonal mechanisms underlying the elevated risk of type 2 diabetes in carriers of TCF7L2 gene.Keywords
This publication has 40 references indexed in Scilit:
- Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell ProliferationJournal of Biological Chemistry, 2008
- Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetesJournal of Clinical Investigation, 2007
- Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphismsDiabetologia, 2007
- TCF7L2 Polymorphisms Modulate Proinsulin Levels and β-Cell Function in a British Europid PopulationDiabetes, 2007
- Type 2 Diabetes TCF7L2 Risk Genotypes Alter Birth Weight: A Study of 24,053 IndividualsThe American Journal of Human Genetics, 2007
- Wnt signaling regulates pancreatic β cell proliferationProceedings of the National Academy of Sciences, 2007
- TCF7L2 polymorphisms are associated with type 2 diabetes in northern SwedenEuropean Journal of Human Genetics, 2007
- Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolutionNature Genetics, 2007
- TCF7L2Polymorphisms and Progression to Diabetes in the Diabetes Prevention ProgramNew England Journal of Medicine, 2006
- Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetesNature Genetics, 2006